Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma

NCT00461084 · clinicaltrials.gov ↗

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: BIAXIN (CLARITHROMYCIN)
DRUG: Biaxin (clarithromycin)

Sponsor

Memorial Sloan Kettering Cancer Center